{
  "retracted": false,
  "timestamp": 1569888000000,
  "updates": [
    {
      "timestamp": 1585256412747,
      "identifier": {
        "doi": "10.1016/j.taap.2019.114708"
      },
      "type": "erratum"
    }
  ],
  "identifier": {
    "doi": "10.1016/j.taap.2015.12.024"
  },
  "publisher": "Elsevier BV",
  "title": "Corrigendum to “Dioscin alleviates BDL- and DMN-induced hepatic fibrosis via Sirt1/Nrf2-mediated inhibition of p38 MAPK pathway”. [Toxicology and Applied Pharmacology 292 (2016) 19–29]"
}
